Nature research paper: The Omicron variant causes milder lung disease in mice and hamsters, which parallels preliminary human clinical data
These authors contributed equally: Peter J.
Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USADepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USACenter for Childhood Infections and Vaccines of Children’s Healthcare of Atlanta, Department of Pediatrics, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USAVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USAThe Research Center for Global Viral Diseases, National Center for Global Health...
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM - NatureNature - <ArticleTitle Language="En" xml:lang="en">Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and...
Les mer »
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagementThe SARS-CoV-2 Omicron variant of concern evades antibody-mediated immunity that comes from vaccination or infection with earlier variants due to accumulation of numerous spike mutations. To understand the Omicron antigenic shift, we determined cryo-...
Les mer »
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesPreclinical experiments in human cells and mice suggest CBD may prevent the replication of SARSCoV2, but the authors advise caution until completion of a clinical trial, citing questions on dosage, formulation, and mode of delivery. ScienceAdvances
Les mer »
Why scientists are racing to develop more COVID antiviralsThe first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Les mer »
Even Mild Covid-19 Can Cause Brain Dysfunction And Cognitive IssuesThe research provides new clues as to why some people with long Covid experience long-term cognitive issues after being infected with the SARS-CoV-2 coronavirus.
Les mer »
Why scientists are racing to develop more COVID antiviralsThe first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Les mer »